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Abstract
Objective:  To  compare  the  results  obtained  with  the  sweat  test  using  the  conductivity  method
and coulometric  measurement  of  sweat  chloride  in  newborns  (NBs)  with  suspected  cystic  ﬁbrosis
(CF) in  the  neonatal  screening  program.
Methods:  The  sweat  test  was  performed  simultaneously  by  both  methods  in  children  with  and
without  CF.  The  cutoff  values  to  conﬁrm  CF  were  >50  mmol/L  in  the  conductivity  and  >60  mmol/L
in the  coulometric  test.
Results:  There  were  444  infants  without  CF  (185  males,  234  females,  and  24  unreported)  sub-
mitted to  the  sweat  test  through  conductivity  and  coulometric  measurement  simultaneously,
obtaining  median  results  of  32  mmol/L  and  12  mmol/L,  respectively.  For  90  infants  with  CF,  the
median values  of  conductivity  and  coulometric  measurement  were  108  mmol/L  and  97  mmol/L,
respectively.  The  false  positive  rate  for  conductivity  was  16.7%,  and  was  higher  than  50  mmol/L
in all  patients  with  CF,  which  gives  this  method  a  sensitivity  of  100%  (95%  CI:  93.8--97.8),  speci-
ﬁcity of  96.2%  (95%  CI:  93.8--97.8),  positive  predictive  value  of  83.3%  (95%  CI:  74.4--91.1),
negative predictive  value  of  100%  (95%  CI:  90.5--109.4),  and  9.8%  accuracy.  The  correlation
between  the  methods  was  r  =  0.97  (p  >  0.001).  The  best  suggested  cutoff  value  was  69.0  mmol/L,
with a  kappa  coefﬁcient  =  0.89.
Conclusion:  The  conductivity  test  showed  excellent  correlation  with  the  quantitative  coulo-
metric test,  high  sensitivity  and  speciﬁcity,  and  can  be  used  in  the  diagnosis  of  CF  in  children
detected through  newborn  screening.
© 2015  Sociedade  Brasileira  de  Pediatria.  Published  by  Elsevier  Editora  Ltda.  All  rights  reserved.
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Condutividade  e  teste  quantitativo  coulométrico  na  triagem  neonatal  para  ﬁbrose
cística
Resumo
Objetivo:  Comparar  os  resultados  obtidos  no  teste  do  suor  pelo  método  da  condutividade  e  a
dosagem coulométrica  de  cloreto  no  suor  em  recém  nascidos  (RN)  suspeitos  da  triagem  neonatal
para ﬁbrose  cística  (FC).
Métodos:  O  teste  do  suor  foi  realizado  simultaneamente  pelos  dois  métodos  em  crianc¸as  com  e
sem FC.  Os  valores  de  corte  para  conﬁrmar  FC  foram  na  condutividade  >  50  mmol/L  e  no  teste
coulométrico  >  60  mmol/L.
Resultados:  Quatrocentos  e  quarenta  e  quatro  RN  sem  FC  (185  do  sexo  masculino,  234  femininos
e 24  não  informado)  realizaram  o  teste  do  suor  por  condutividade  e  dosagem  coulométrica
simultaneamente  e  obtiveram  resultado  mediano  de  32  mmol/L  e  12  mmol/L  respectivamente.
Para os  noventa  RN  com  FC  os  valores  medianos  de  condutividade  e  dosagem  coulométrica
foram 108  mmol/L  e  97  mmol/L  respectivamente.  O  índice  de  falso  positivo  para  condutividade
foi de  16,7%  e  em  todos  os  pacientes  FC  foi  superior  a  50  mmol/L  conferindo  ao  método  100%
de sensibilidade  (IC  95%  =  93,8  a  97,8),  especiﬁcidade  de  96,2%  (IC  95%  =  93,8  a  97,8),  valor
preditivo positivo  83,3  (IC  95%  =  74,4  a  91,1),  valor  preditivo  negativo  100%  (IC  95%  =  90,5  a
109,4) e  acurácia  9,8%.  A  correlac¸ão  entre  os  métodos  foi  de  r  =  0,97  (p  >  0,001).O  melhor  valor
de corte  sugerido  foi  de  69,0  mmol/L,  coeﬁciente  de  kappa  =  0,89.
Conclusão:  O  teste  da  condutividade  apresentou  excelente  correlac¸ão  com  o  quantitativo
coulométrico,  alta  sensibilidade  e  especiﬁcidade,  podendo  ser  utilizado  no  diagnóstico  da  FC
em crianc¸as  detectadas  pela  triagem  neonatal.
© 2015  Sociedade  Brasileira  de  Pediatria.  Publicado  por  Elsevier  Editora  Ltda.  Todos  os  direitos
reservados.
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Cystic  ﬁbrosis  (CF)  is  an  autosomal  recessive  disease,  result-
ing  from  mutations  in  the  gene  located  in  the  long  arm
of  chromosome  7,  cystic  ﬁbrosis  transmembrane  conduc-
tance  regulator  (CFTR),  with  an  incidence  of  about  1:10,000
in  Brazil.1,2 It  is  a  multisystemic  disease  and  pulmonary
involvement  accounts  for  the  majority  of  patient  mor-
bimortality.  The  clinical  signs  and  symptoms  include  chronic
pulmonary  disease,  pancreatic  failure,  and  abnormalities  in
the  gastrointestinal  tract  and  sweat  gland  secreting  chan-
nels,  with  an  increase  of  chloride  concentration  in  the
sweat.3--5 Survival  depends  on  early  diagnosis  conﬁrmation
and  treatment  initiation  at  the  early  stages  of  the  disease.
Identiﬁcation  is  attained  by  the  presence  of  signs  or  symp-
toms;  family  history;  altered  immunoreactive  trypsin  (IRT)
in  neonatal  screening  and  conﬁrmed  by  positive  sweat  test  in
two  separate  measurements,  presence  of  two  CF  mutations,
or  altered  nasal  potential  difference  test.  The  latter  test
requires  considerable  skill,  and  is  rarely  used  in  Brazil.6,7
In  Brazil,  CF  screening  was  introduced  in  the  National
Neonatal  Screening  Program  (PNTN)  in  2001  with  the
immunoreactive  trypsin  test  (IRT)  performed  in  blood  col-
lected  from  newborns  and  the  sweat  test.2
The  conﬁrmatory  test,  the  gold  standard,  is  the  quan-
titative  analysis  of  electrolytes  in  sweat,  with  an  accuracy
>90%.8 Sweating  is  stimulated  by  pilocarpine,  performed  by
iontophoresis;  sweat  is  obtained  using  the  Gibson  and  Cooke
method.  However,  skill  is  necessary  to  prevent  evaporation
during  collection  and  the  subsequent  determination  of  sweat
weight  on  an  analytical  scale,  followed  by  the  accurate
chemical  composition  of  the  sample.  The  sweat  collection
system  with  a  capillary  microtube  Macroduct® (Wescor  Inc.,
T
H
0ogan,  UT,  USA)  has  been  widely  used  due  to  its  simplicity
nd  efﬁciency.  The  microtube  prevents  evaporation,  and  the
eighing  and  dilution  steps  are  eliminated.
Sweat  can  have  its  ionic  composition  analyzed  immedi-
tely  or  be  submitted  to  a  conductivity  analyzer  prior  to
hemical  determination.9 The  test  is  positive  if  the  chloride
oncentration  is  >60  mmol/L  in  at  least  two  independent
easurements.8,10 For  infants  younger  than  6  months,  val-
es  between  30  mmol/L  and  50  mmol/L  are  considered
uspect.9--11 The  conductivity  test  also  constitutes  an  alter-
ative  and  valid  method  for  the  laboratory  diagnosis  of
F.7,8,10 The  system  measures  the  capacity  of  the  sweat
o  conduct  electrical  current  in  milliamperes  (mAs),  which
epends  on  the  concentration  of  Na+ and  Cl−.12
The  Sweat  Check  3120® (Wescor  Inc.,  Logan,  UT,  USA)
onductivity  analyzer,  speciﬁcally  designed  for  use  with
he  Macroduct® (Wescor  Inc.,  Logan,  UT,  USA)  sweat  col-
ector,  measures  conductivity  in  a  6--10  L  sample.  Values
80  mmol/L  and  a compatible  clinical  setting  justify  the
tart  of  treatment,  whereas  values  between  50  mmol/L
nd  80  mmol/L  indicate  the  need  to  perform  the  quanti-
ative  test,  because  conductivity  is  considered  a  screening
ethod,  as  it  is  not  selective  to  the  chloride  ion.8--10 The
im  of  this  study  was  to  compare  chloride  levels  in  sweat  by
he  quantitative  coulometric  test  with  conductivity  values  in
ewborns  with  and  without  CF,  from  the  neonatal  screening
rogram  of  the  state  of  Paraná.
ethodshis  study  was  approved  by  the  Ethics  Committee  of
C-UFPR,  registered  under  No.  271EXT025/2008-06,  CAAE
117.0.208.000-08.  This  was  a  prospective,  cross-sectional,
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ohort  study  that  evaluated  the  neonatal  screening  pro-
ram  for  CF  in  the  state  of  Paraná.  From  January  2002
o  December  2008,  1,218,642  newborns  were  evaluated.
nitial  screening  was  performed  through  IRT  measurement
n  blood  samples  obtained  from  dermal  puncture  of  the
eel,  impregnated  on  ﬁlter  paper  and  then  analyzed  by
mmunoﬂuorometric  assay  in  a  AutoDELFIA  system  (Perkin
lmer®,  MA,  USA),  conducted  in  three  stages.
Children  with  altered  values  ≥70  mg/L  in  two  different
amples  obtained  during  the  ﬁrst  30  days  of  life  were  con-
acted  by  a  team  of  social  workers  through  active  search  to
e  submitted  to  a  free  sweat  test  (conductivity  followed  by
oulometric  quantitative  test  for  chloride  measurement)  in
rder  to  rule  out  suspicion  for  CF.
An  informative  questionnaire  on  the  tests  was  applied
o  parents  or  guardians,  who  after  being  recalled,  volun-
eered  and  consented  to  its  performance.  A  total  of  2309
nfants  were  submitted  to  the  test  using  both  methods;  a
epeated  test  was  required  in  99  infants  (4.3%)  due  to  insuf-
cient  quantity  of  sweat.  Of  the  2309  children,  90  cases  of
F  were  conﬁrmed.  For  the  study,  a  group  consisting  of  444
nfants  was  selected  by  convenience  from  the  2219  children
ith  normal  sweat  test,  as  well  as  the  90  cases  with  positive
weat  test  and  conﬁrmed  CF.
weat  collection
weating  was  induced  by  the  iontophoresis  technique
ith  pilocarpine.  Gelatinous  discs  impregnated  with  0.5%
ILOGEL® (Pilocarpine  hydrochloride,  Alcon  Laboratories,
K)  were  afﬁxed  using  standard  WESCOR® electrodes
Wescor  Inc.,  Logan,  UT,  USA),  positive  and  negative  ﬁtting
he  child’s  arm  perfectly  after  rigorous  asepsis  and  cleaning
ith  deionized  water.  The  device  promotes  the  stimulation
hrough  an  iontophoretic  current  of  1.5  mA  for  5  min.  Pilo-
arpine  is  ionized  and  guided  to  an  area  of  skin  that  has
weat  glands,  preferably  in  the  anterior  forearm.8,9 If  this
ite  was  not  adequate  for  the  collection,  then  the  anterior
high  area  was  used.
After  stimulation,  the  area  was  cleaned  with  deionized
ater  and  the  sweat  collected  directly  in  a  disposable
acroduct® (Wescor  Inc.,  Logan,  UT,  USA)  ﬁrmly  afﬁxed  to
he  site,  according  to  the  manufacturer’s  recommendation.
ollection  time  did  not  exceed  30  min,  nor  was  it  inferior  to
0  min.9 The  mean  rate  during  the  collection  was  not  less
han  1  g/m2/min  or  10  L of  sweat  using  the  Macroduct®
Wescor  Inc.,  Logan,  UT,  USA)  collection  system,  the  min-
mum  volume  of  sweat  required  for  this  device.9,13
onductivity  method
mmediately  after  collection,  the  sweat  sample  was  sub-
itted  to  the  conductivity  test  by  the  Sweat  Check  3120®
evice.  The  normal,  borderline,  and  abnormal  values  were
stablished  according  to  the  equation  associating  conductiv-
ty  with  chloride.11,13 After  the  conductivity  was  measured,
he  same  sweat  sample,  placed  in  an  Eppendorf  tube,  was
mmediately  sent  for  the  quantitative  measurement  of  chlo-
ide.
To  prevent  the  conductivity  result  from  inﬂuencing  the
uantitative  measurement  of  chloride,  the  two  techniques
9
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o
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ere  performed  by  different  teams  that  were  unaware  of
ach  other’s  results.
uantitative  measurement  of  chloride  by
oulometry
or  this  measurement,  a  digital  Labconco® chloridometer
Labconco®,  KS,  USA)  was  utilized,  which  is  a device  that
erforms  colorimetric  titration  of  chloride  ions.  A  quantity
f  10  L  of  sweat  is  necessary  for  the  reaction  to  occur  within
econds  of  contact  with  the  reagent  solution  and  the  pair  of
lectrodes,  providing  a  digital  readout  in  mmol/L.14--16
The  method  monitoring  for  the  initial  screening  was  car-
ied  out  according  to  the  internal  kit  controls,  TIRIQAS
France)  and  CDC  (Centers  for  Disease  Control  and  Pre-
ention,  GA,  USA).  For  the  quality  control  of  sweat  tests,
aCl  commercial  standard  solutions  at  concentrations  of
0  mmol/L,  70  mmol/L,  and  130  mmol/L  were  used  in  all
xperiments,  in  addition  to  previously  prepared  internal
aCl  standards  of  10  mmol/L,  50  mmol/L,  and  100  mmol/L.
his  study  was  conducted  in  an  institution  accredited  by  the
inistry  of  Health  for  neonatal  screening  for  CF.
At  hospital  discharge,  the  service  usually  distributes  the
‘information  for  parents’’  leaﬂet,  which  contains  explana-
ions  on  neonatal  screening.  When  necessary,  the  sweat  test
as  performed  with  prior  notice  and  after  active  search  by  a
pecialized  team,  and  the  parents  were  informed  by  means
f  a  questionnaire  applied  at  the  test  site.  As  this  is  a  rou-
ine  test  at  the  accredited  service,  an  informed  consent  was
ot  required.
tatistical  analysis
he  estimate  of  the  difference  between  means  was  per-
ormed  by  Student’s  t-test  and  analysis  of  variance  (ANOVA),
hereas  Pearson’s  chi-squared  test  was  used  for  the
ifference  between  frequencies.  Pearson’s  correlation  coef-
cient  was  calculated  between  the  quantitative  coulometric
ethod  (gold  standard)  and  the  conductivity  test,  with  the
appa  coefﬁcient  used  to  estimate  the  correlation  between
he  methods.  A  receiver  operating  characteristic  (ROC)
urve  was  constructed  to  estimate  the  cutoff  point  and  sen-
itivity  and  speciﬁcity  rates  of  the  conductivity  test,  with
he  coulometric  method  employed  as  the  gold  standard.
 minimum  signiﬁcance  level  of  5%  was  considered  for  all
ests  using  the  Statistica  program  --  Statsoft® (StatSoft,  Inc.,
ELL®, OK,  USA).
esults
he  study  included  1,218,642  newborns  from  the  neona-
al  screening  program  of  the  state  of  Paraná,  of  whom
3,235  (1.08%)  had  a  ﬁrst  test  result  (IRT-1)  >70  g/L  and  were
ecalled  for  further  testing  (IRT-2).  Of  these,  10,926  (82.5%)
ormalized  and  2309  (17.4%)  persisted  with  altered  values
nd,  thus,  were  submitted  to  the  sweat  test,  through  both
ethods,  which  resulted  in  2219  (96.1%)  normal  results  and
0  (3.9%)  CF  cases.  Of  the  2309  infants  submitted  to  the
weat  test,  two  groups  were  separated  for  convenience,
ne  with  444  individuals  without  CF  and  another  with  90
ndividuals  with  CF.
Sweat  conductivity  in  cystic  ﬁbrosis  593
Table  1  Quantitative  measurement  of  chloride  and  conductivity  in  patients  without  CF.
Mean  (SD)  95%  CI  Median  Minimum  Maximum
Chloride  (n  =  444)  26.0  ±  32.2  23.0--29.0  12.0  3.0  35.0
Conductivity  (n  =  444) 44.1  ±  29.5 41.3--46.8  32.0  6.0  48.0
CF, cystic ﬁbrosis; SD, standard deviation; 95% CI, 95% conﬁdence interval.
Chloride and conductivity values are expressed in mmol/L.
Table  2  Quantitative  measurement  of  chloride  and  of  conductivity  in  CF  patients.
Mean  (SD) 95%  CI  Median  Minimum  Maximum
Chloride  1  (n  =  90)  91.9  ±  19.0  87.5--96.3  97.0  60.0  110.0
Conductivity  1  (n  =  90)  102.4  ±  18.8  98.5--106.3  108.0  53.0  133.0
Chloride 2  (n  =  90)  91.7  ±  19.0  86.4--96.9  97.5  60.0  115.0
Conductivity  2  (n  =  90)  106.4  ±  18.9  102.6--110.2  110.0  57.0  129.0
 ﬁbrosis.
nd examinations, respectively.
Table  3  Concordance  between  the  conductivity  and  the
coulometric  quantitative  test  for  chloride  measurement.
Coulometric  test  Total
Positive  Negative
Conductivity
Positive 90  14  104
Negative  0  430  430
Total 90  444  534
Kappa coefﬁcient = 0.89; (Fisher’s exact test) p < 0.001; sen-
sitivity = 100% (95.9--100); speciﬁcity = 96.8% (94.8--98.1); PPV
(positive predictive value) = 86.5%; NPV (negative predictive
value) = 100%; accuracy = 97.4%; false positive = 13.5%; false neg-
ative = 0; positive likelihood ratio = 31.7 (18.9--53.1); negative
likelihood ratio = 0.
Conductivity method
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69.9 mmol/L SD, standard deviation; 95% CI, 95% conﬁdence interval; CF, cystic
Chloride and conductivity 1 and 2 correspond to the ﬁrst and seco
Chloride and conductivity values are expressed in mmol/L.
In  the  group  without  CF,  185  (41.6%)  were  males,  234
(52.7%)  females,  and  for  25  cases  (5.6%)  this  information  was
not  available.  As  for  ethnicity,  420  (94.6%)  were  white  and
in  24  cases  (5.4%)  ethnicity  was  unknown.  The  mean  birth
weight  was  3228.8  ±  2352.8  g  (95%  CI:  3002.4--3455.4  g).  In
the  group  with  CF,  the  distribution  between  the  genders
and  ethnicity  was  46  (51.1%)  males,  44  (48.8%)  females,
85  (94.5%)  whites  and  5  (5.5%)  non-whites.  The  mean
birth  weight  was  3091.2  ±  477.9  g  (95%  CI:  2000.0--3997.0  g).
The  sweat  volume  collected  from  all  children  was  greater
than  15  L,  allowing  both  methods  to  be  used.  In  the
non-CF  group,  median  sweat  test  results  by  coulometry
and  conductivity  were  12  mmol/L  and  32  mmol/L,  respec-
tively  (Table  1).  In  the  group  with  CF,  median  values  were
97.0  mmol/L  and  108  mmol/L,  respectively,  showing  good
correlation  between  the  tests,  considering  that  conductivity
measures  all  ions  present  in  sweat  (Table  2).
In  the  group  with  CF,  14  (3.15%)  showed  high  conduc-
tivity  (>50.0  mmol/L),  but  normal  chloride  measurements
(<60.0  mmol  Cl−/L),  which  were  considered  false  positive
results.  The  results  showed  excellent  correlation  between
the  methods  and  properties  obtained  when  comparing  them,
considering  the  quantitative  measurement  of  chloride  as  the
gold  standard  (Table  3).
All  CF  patients  showed  conductivity  values  >80  mmol/L,
which  gives  the  test  a  sensitivity  of  100%  (95%  CI:  94.8--100),
speciﬁcity  of  96.2%  (95%  CI:  93.8--97.8),  positive  predic-
tive  value  of  83.3%  (95%  CI:  74.4--91.1),  negative  predictive
value  of  100%  (95%  CI:  90.5--109.4),  accuracy  of  96.8%,  false
positive  rate  of  16.7%,  zero  false  negative  rate,  positive  like-
lihood  ratio  of  31.7  (18.9--53.1),  and  zero  negative  likelihood
ratio.  The  correlation  coefﬁcient  between  the  two  methods
was  0.97,  with  kappa  factor  of  0.89  (p  <  0.001).  The  ROC
curve  (Fig.  1)  showed  100%  overlap  under  the  curve  with
the  conductivity  method  and  the  suggested  cutoff  value  was
69.0  mmol/L.Discussion
The  assessment  carried  out  in  this  study  shows  the  conduc-
tivity  method  can  be  used  as  a  diagnostic  tool,  considering
100-specificity
Figure  1  ROC  curve  between  the  coulometric  quantitative
method  (gold  standard)  and  the  conductivity  method.
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hat  all  statistical  tests  used  to  compare  it  with  the  coulo-
etric  quantitative  chloride  measurement,  which  is  the  gold
tandard,  indicated  strong  accuracy.  The  cutoff  value  sug-
ested  by  the  ROC  curve  analysis  was  69  mmol/L,  with  the
onductivity  values  of  60--69  mmol/L  considered  as  equivo-
al  range  values  (p  =  0.001).  The  results  of  this  study  suggest
hat  the  analytical  method  of  conductivity  can  be  a  deﬁni-
ive  and  reliable  diagnostic  procedure  for  CF.  The  correlation
oefﬁcient  (r  =  0.97)  found  in  this  study  shows  good  conver-
ence  between  these  methods.
Although  some  studies  have  shown  that  the  conductivity
orrelates  well  with  the  chloride  concentrations,7,13,14,17--19
his  fact  is  not  accepted  by  the  North  American  National
linical  and  Laboratory  Standards  Institute  (CLSI)  as  a
ethod  used  for  deﬁnitive  diagnosis,  relegating  it  to  the
tatus  of  ‘‘screening  method’’,13,14 and  it  recommends  that
ndividuals  with  sweat  conductivity  of  50  mmol/L  be  submit-
ed  to  quantitative  chloride  assessment.
Currently,  the  quantitative  analysis  of  chloride  or  sodium
s  the  most  widely  used  and  conclusive  method  for  the  diag-
osis  of  CF,  as  more  than  99%  of  individuals  homozygous  for
he  CF  gene  have  chloride  and  sodium  in  sweat  >60  and
0  mmol/L,  respectively.15,20 Some  studies  have  suggested
hat  the  cutoff  for  neonates  should  be  30  mmol/L,  to  prevent
he  possibility  of  false  negative  results.10,15 The  electrolytes
n  sweat  may  be  transiently  elevated  during  the  ﬁrst  24  h
f  life.  For  this  reason  it  is  suggested  that  the  test  be  per-
ormed  48  h  after  birth.15
The  present  study  has  shown  that  conductivity  is  capa-
le  of  discriminating  CF  patients  from  normal  subjects,  with
6.7%  false  positive  results  (Table  3).  As  the  conductivity
esults  from  the  sum  of  electrolytes  in  sweat,  the  results
re  expected  to  be  higher.  The  median  conductivity  in  cases
ithout  CF  were,  respectively,  32  mmol/L  and  12  mmol/L
nd,  in  cases  with  CF,  108  mmol/L  and  97  mmol/L  in  the  ﬁrst
est,  and  110  mmol/L  and  97.5  mmol/L  in  the  second  test,
erformed  on  different  days  (Tables  1  and  2).  The  conduc-
ivity  results  were  always  higher  and  there  were  no  false
egative  cases.
The  results  suggest  that  this  analytical  method,  accord-
ng  to  the  criteria  of  100%  sensitivity  (95%  CI:  94.8--100),
9.5%  speciﬁcity  (95%  CI:  93.8--97.8),  and  conductivity  value
f  69.0  mmol/L,  should  be  considered  conﬁrmatory  for  the
isease.  No  false-negative  CF  cases  were  reported  in  the
creened  population,  which  can  occur,  as  there  are  some
utations  in  the  CFTR  gene  that  cause  sweat  electrolytes
o  remain  within  the  normal  range.7
Studies  have  shown  an  excellent  correlation  between
he  conductivity  and  the  coulometric  titration  of  chloride.
ammond  et  al.  evaluated  conductivity  and  the  chloride
oncentration  in  sweat  in  471  individuals  without  CF  and
ound  mean  values  of  33.4  mmol/L  (13--87  mmol/L)  and
6.4  mmol/L  (5--60  mmol/L)  for  the  two  methods,  respec-
ively.  In  the  43  patients  with  CF,  the  mean  conductivity
alue  was  113.1  mmol/L  (90--136  mmol/L),  and  for  chloride,
8.8  mmol/L  (77--117  mmol/L).  There  was  a  good  correlation
etween  the  methods  (r  =  0.97).13
Lezana  et  al.  compared  the  two  methods  in  3834  patients
ith  clinical  suspicion,  whose  age  ranged  from  1.8  to  54
ears;  the  median  conductivity  found  in  patients  without
nd  with  CF  was  36  mmol/L  and  111  mmol/L,  respectively.
he  correlation  coefﬁcient  between  the  two  methods  was
(
m
aDomingos  MT  et  al.
.60  (p  <  0.001).  The  ROC  curve  showed  high  concordance
etween  them,  ruling  out  CF  for  conductivity  <75  mmol/L
nd  conﬁrming  CF  for  values  ≥90  mmol/L,  with  99.7%  sensi-
ivity,  100%  speciﬁcity,  and  PPV  and  NPV  of  100%  and  99.97%,
espectively.  The  kappa  coefﬁcient  was  0.99.14 The  results
btained  in  this  study,  in  a  population  consisting  essentially
f  newborns,  corroborate  the  results  of  these  authors.
Mastella  et  al.,  evaluating  287  individuals,  found
ean  values  of  chloride  and  conductivity  of  16.3  mmol/L
4--60  mmol/L)  and  39.8  mmol/L  (19--87  mmol/L)  in
atients  without  CF,  respectively;  in  CF  patients,  val-
es  were  95.7  mmol/L  (32--121  mmol/L)  and  112  mmol/L
45--173  mmol/L),  respectively.21
Mattar  et  al.,  comparing  the  classical  method  of  Gib-
on  and  Cooke  and  conductivity  in  738  children,  found
edian  chlorine  values  and  sweat  conductivity  of  11  mmol/L
nd  25  mmol/L,  respectively,  in  714  children.  In  the  24
atients  with  CF,  the  mean  values  found  were  87  mmol/L
nd  103  mmol/L,  respectively.  These  authors  found  a  sensi-
ivity  of  83.3%,  speciﬁcity  of  99.7%,  PPV  of  90.9%,  and  NPV
f  99.4%,  respectively,  for  conductivity  values  >90  mmol/L.
he  conductivity  value  used  to  rule  out  CF  was  <75  mmol/L.
ood  agreement  was  observed  between  the  methods  (kappa
oefﬁcient  =  0.93).18
Riedi  et  al.  found  a  strong  correlation  between  sodium
easurement  and  conductivity  in  sweat.  Of  the  175  patients
ithout  CF,  the  mean  values  of  sodium  and  conductiv-
ty  were  36.3  mmol/L  (12--75  mmol/L)  and  40.9  mmol/L
16--75  mmol/L);  in  the  31  patients  with  CF,  they
ere  113.2  mmol/L  (80--146  mmol/L)  and  118.5  mmol/L
84--155  mmol/L).  Although  sodium  measurement  is  not  rec-
mmended  in  the  diagnosis  of  CF,  these  authors  found  a  good
orrelation  between  the  methods  (r  =  0.99)  (p  <  0.0001).19
Khoa-Nguyen  et  al.  demonstrated  the  linearity  between
he  colorimetric  titration  and  the  coulometric  and  con-
uctivity  methods  in  the  range  of  10--120  mmol/L.  They
stablished  a  correspondence  rate  of  the  coulometric  mea-
urement  and  the  conductivity  ratio  of  30,  40,  and  60  mmol  L
o  57,  66,  and  84  mmol/L,  respectively.  These  authors  sup-
ort  that  a  sweat  test  for  conductivity  <50  mmol/L  rules  out
he  CF  diagnosis  in  the  absence  of  clinical  signs.17 In  the
resent  study,  all  90  CF  cases  showed  a  conductivity  result
50  mmol/L,  conﬁrming  these  authors’  ﬁndings.
The  apparent  advantage  of  the  Macroduct® system  is
he  capacity  to  obtain  direct  readings  of  the  results  with
mall  amounts  of  sweat.11 Two  positive  tests  carried  out
n  different  dates  are  required  to  conﬁrm  the  diagnosis.15
nadequate  sweating  can  distort  the  results  and  thus,  a  min-
mum  acceptable  sweat  volume  of  15  L  collected  in  30  min
s  recommended.11,13,15 LeGrys  et  al.  deﬁned  the  follow-
ng  as  sufﬁcient  and  optimal  sweat  volume:  at  least  75  mg
sing  the  Gibson--Cooke  method22 or  at  least  10--15  L  by
he  Macroduct®,23 recommendations  that  were  followed  in
his  study.
Some  authors  evaluated  the  repetition  rate  of  the  sweat
est  for  inappropriate  volume,  and  recommended  a  percent-
ge  limit  of  5%  of  retest  in  patients  aged  >3  months.23,24 In
his  study,  it  was  necessary  to  repeat  the  test  in  99  children
4.3%)  due  to  insufﬁcient  volume,  thus  within  the  recom-
ended  rate.
The  preference  for  the  conductivity  method  is  justiﬁed,
s  it  is  easy  to  perform  when  compared  to  traditional
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quantitative  measurements  of  chloride,  especially  those
using  ﬁlter  paper  or  gauze  to  collect  sweat,  in  which  the
sample  quantity  can  be  a  limiting  factor.  The  results  of
this  study  corroborate  those  previously  published  by  other
authors  and  reinforce  the  use  of  this  test  as  a  diagnostic
method,  as  the  operator  has  less  inﬂuence  on  the  quality
of  results.
This  study  suggests  that  the  conductivity  test  is  valid  for
the  quantitative  analysis  of  chloride  in  sweat  to  diagnose  or
exclude  CF  and  can  be  considered  as  a  diagnostic  method.
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